Get started
Author

Jonathan Pai

Observed names: J. Pai, J.S. Pai, Jon S. Pai, Jonathan S Pai, Jonathan S. Pai, Pai, Jonathan, Pai, Jonathan S.
Observed institutions: University of Southern California, LAC+USC Medical Center, University of South Carolina, University of California, San Francisco, USC Norris Comprehensive Cancer Center, Stanford Medicine, Stanford Cancer Institute, California University of Science and Medicine, Stanford University
ORCID: 0000-0002-7843-6934
Observed ORCID: 0000-0002-7843-6934
OpenAlex ID: A5031022786
Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma
2014 · Joseph M. Herman, Daniel T. Chang, et al. · Cancer · 542
PDF
Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients
2020 · William C. Chen, Joe D. Baal, et al. · International Journal of Radiation Oncology*Biology*Physics · 94
Baseline Metabolic Tumor Volume and Total Lesion Glycolysis Are Associated With Survival Outcomes in Patients With Locally Advanced Pancreatic Cancer Receiving Stereotactic Body Radiation Therapy
2014 · Avani S. Dholakia, Muhammad Chaudhry, et al. · International Journal of Radiation Oncology*Biology*Physics · 78
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.
2013 · Aaron T Wild, Susan M Hiniker, et al. · PubMed · 78
The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer
2015 · Margaret M. Kozak, Rie von Eyben, et al. · American Journal of Clinical Oncology · 53
Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastases
2021 · William C. Chen, Ulysis H. Baal, et al. · JAMA Oncology · 51
PDF
Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer
2015 · Margaret M. Kozak, Eric M. Anderson, et al. · Pancreas · 50
Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer
2015 · Margaret M Kozak, Rie von Eyben, et al. · Journal of Clinical Pathology · 47
Factors Associated with Osteoid Osteoma Recurrence after CT-Guided Radiofrequency Ablation
2019 · Joe D. Baal, Jonathan S. Pai, et al. · Journal of Vascular and Interventional Radiology · 44
Image-Guided Percutaneous Ablation of Adrenal Metastases: A Meta-Analysis of Efficacy and Safety
2021 · Simon Pan, Joe D. Baal, et al. · Journal of Vascular and Interventional Radiology · 26
Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer
2016 · Avani D. Rao, Elizabeth A. Sugar, et al. · Practical Radiation Oncology · 26
A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3
2016 · David B. Shultz, Jonathan Pai, et al. · PLoS ONE · 17
PDF
Preoperative MR Imaging to Differentiate Chordoid Meningiomas from Other Meningioma Histologic Subtypes
2019 · J.D. Baal, W.C. Chen, et al. · American Journal of Neuroradiology · 15
PDF
The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer
2014 · M. Kozak, J. Pai, et al. · International Journal of Radiation Oncology*Biology*Physics · 14
PDF
Emerging precision therapeutics for pancreatic ductal adenocarcinoma: KRAS and beyond
2026 · Ani Misirian, Jonathan Pai, et al. · Therapeutic Advances in Medical Oncology · 3
“What is the mechanism?”: Cues, barriers, and opportunities to discuss foundational science during internal medicine rounds
2022 · Jonathan S. Pai, Heidi E. Kirsch, et al. · Medical Teacher · 3
Impact of CTNNB1 alterations on outcomes in patients with hepatocellular carcinoma (HCC).
2024 · Jonathan Pai, Yasmine Baca, et al. · Journal of Clinical Oncology · 2
PDF
Improving Delays in Obtaining Lenalidomide at a Large Safety Net Hospital
2021 · Jonathan S. Pai, Ronak Patel, et al. · Blood · 2
Statin Use as a Predictor of Outcome in Colorectal Cancer
2014 · E. Anderson, R. Von Eyben, et al. · International Journal of Radiation Oncology*Biology*Physics · 2
PDF
A novel biomarker panel examining response to gemcitabine (G) with or without erlotinib (E) for pancreatic cancer (PA) therapy in NCIC clinical trials group PA.3.
2014 · David Shultz, Jonathan Pai, et al. · Journal of Clinical Oncology · 2
Effects of virtual reality on pain and anxiety in patients with cancer undergoing bone marrow biopsy.
2023 · Jacek K. Pinski, Savannah Mohacsi, et al. · Journal of Clinical Oncology · 1
Stereotactic Body Radiotherapy for Adrenal Gland Metastases: A Pooled Meta-Analysis of 1006 Patients
2020 · William Chen, Joe Baal, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
Stereotactic body radiotherapy for hepatocellular carcinoma in patients with poor liver function.
2018 · Jason Chan, Spencer Behr, et al. · Journal of Clinical Oncology · 1
Circulating Tumor DNA as a Biomarker for Pancreatic Adenocarcinoma
2014 · E. Osmundson, A.M. Newman, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
Pre-SBRT metabolic tumor volume and total lesion glycolysis to predict survival in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy.
2014 · Avani Satish Dholakia, Muhammad Ali Chaudhry, et al. · Journal of Clinical Oncology · 1
Works count: 37
Citation count: 1,158
H-index: 14
I10-index: 14
Year
Topic
Type